Black and white version
Local websites
Businesses
Other websites
General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

More information

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

More information

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Institutional investors

Private investors

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Featured news:

RECENT STORIES

Longevity with Vitality: Japanese Elders Provide Examples for Healthy Aging

Longevity with Vitality: Japanese Elders Provide Examples for Healthy Aging

Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging

Posted: Jul 10, 2014
Cancer Researcher’s Career Inspired by Childhood Loss (Video)

Cancer Researcher’s Career Inspired by Childhood Loss (Video)

The loss of a relative helped to shape the future career of a promising young virologist.

Posted: Jun 10, 2014
Combination Therapies: Seeking to Block Cancer’s Pathways to Growth

Combination Therapies: Seeking to Block Cancer’s Pathways to Growth

New cancer treatments have the potential to halt the growth of cancer cells with fewer side effects than traditional methods like chemotherapy.

Posted: Jun 4, 2014
2 Million Kids Receive Malaria Medicine (Video)

2 Million Kids Receive Malaria Medicine (Video)

Ahead of World Malaria Day, Novartis and Malaria No More delivered 2 million pediatric antimalarials to Zambia provided through the Power of One campaign.

Posted: Apr 22, 2014
12345

Novartis announced its results for the second quarter of 2014 on July 17.

What's new

Stock chart

NOVZn 87.75 CHF

-0.50 (-0.57%)

Sep 23, 17:30 CET

Stock performance

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, visit About cookies page.
Don't show me this again